Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leading Biopharm is a clinical-stage biopharmaceutical company based in Hangzhou, China, focused on the discovery and development of innovative oncology therapeutics. The company leverages its proprietary drug discovery platform to develop a diverse pipeline of small molecules and biologics, including monoclonal and bispecific antibodies. Their lead programs target well-validated pathways such as PD-1/PD-L1 and VEGF, with several candidates currently in Phase 1 and Phase 2 clinical trials for various solid tumors. Leading Biopharm aims to address significant unmet medical needs in the global oncology market through both internal R&D and strategic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leading Biopharm.